Global Business Travel Group, Inc. (GBTG) Income Tax Expense (Benefit) USD 2021 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Global Business Travel Group, Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from 2021 to 2024.
  • Global Business Travel Group, Inc. Income Tax Expense (Benefit) for the quarter ending March 31, 2024 was $27 M.
  • Global Business Travel Group, Inc. Income Tax Expense (Benefit) for the twelve months ending March 31, 2024 was $26 M.
  • Global Business Travel Group, Inc. annual Income Tax Expense (Benefit) for 2023 was -$9 M, a 85.2% increase from 2022.
  • Global Business Travel Group, Inc. annual Income Tax Expense (Benefit) for 2022 was -$61 M, a 67.2% increase from 2021.
  • Global Business Travel Group, Inc. annual Income Tax Expense (Benefit) for 2021 was -$186 M, a 28.3% decline from 2020.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $26 M $27 M +$35 M Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-07
Q4 2023 -$9 M $3 M +$25 M Oct 1, 2023 Dec 31, 2023 10-K 2024-03-13
Q3 2023 -$34 M -$2 M +$8 M +80% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-07
Q2 2023 -$42 M -$2 M +$2 M +50% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-10
Q1 2023 -$44 M -$8 M +$17 M +68% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-07
Q4 2022 -$61 M -$22 M Oct 1, 2022 Dec 31, 2022 10-K 2024-03-13
Q3 2022 -$10 M +$21 M +67.7% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-07
Q2 2022 -$4 M +$69 M +94.5% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 -$25 M Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q3 2021 -$31 M Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 -$73 M Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.